Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Transdermal Scopolamine market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Transdermal Scopolaminemarket, defines the market attractiveness level of Transdermal Scopolamine market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Transdermal Scopolamine industry, describes the types of Transdermal Scopolamine market, the applications of major players and the market size, and deeply analyzes the current situation of the global Transdermal Scopolamine market and the development prospects and opportunities of Transdermal Scopolamine industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Transdermal Scopolamine market in Chapter 13.
By Player:
Baxter International Inc
Caleb Pharmaceuticals Inc
GlaxoSmithKline plc
Perrigo Company plc
Novartis AG
Myungmoon Pharma Co LTD
By Type:
Tablet Type
Syrups Type
Injections Type
Patch Type
Gel Type
By End-User:
Hospital
Clinic
Ambulance Center
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Transdermal Scopolamine Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Transdermal Scopolamine Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Transdermal Scopolamine Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Transdermal Scopolamine Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Transdermal Scopolamine Market Analysis and Outlook to 2022
-
7.1 Global Transdermal Scopolamine Consumption (2017-2022)
-
7.2 United States Transdermal Scopolamine Consumption (2017-2022)
-
7.3 Europe Transdermal Scopolamine Consumption (2017-2022)
-
7.4 China Transdermal Scopolamine Consumption (2017-2022)
-
7.5 Japan Transdermal Scopolamine Consumption (2017-2022)
-
7.6 India Transdermal Scopolamine Consumption (2017-2022)
-
7.7 South Korea Transdermal Scopolamine Consumption (2017-2022)
8 Region and Country-wise Transdermal Scopolamine Market Analysis and Outlook to 2028
-
8.1 Global Transdermal Scopolamine Consumption Forecast (2022-2028)
-
8.2 United States Transdermal Scopolamine Consumption Forecast (2022-2028)
-
8.3 Europe Transdermal Scopolamine Consumption Forecast (2022-2028)
-
8.4 China Transdermal Scopolamine Consumption Forecast (2022-2028)
-
8.5 Japan Transdermal Scopolamine Consumption Forecast (2022-2028)
-
8.6 India Transdermal Scopolamine Consumption Forecast (2022-2028)
-
8.7 South Korea Transdermal Scopolamine Consumption Forecast (2022-2028)
9 Global Transdermal Scopolamine Market Outlook by Types and Applications to 2022
-
9.1 Global Transdermal Scopolamine Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Tablet Type Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Syrups Type Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Injections Type Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Patch Type Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Gel Type Consumption and Growth Rate (2017-2022)
-
9.2 Global Transdermal Scopolamine Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Clinic Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Ambulance Center Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Others Consumption and Growth Rate (2017-2022)
10 Global Transdermal Scopolamine Market Outlook by Types and Applications to 2028
-
10.1 Global Transdermal Scopolamine Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Tablet Type Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Syrups Type Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Injections Type Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Patch Type Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Gel Type Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Transdermal Scopolamine Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Ambulance Center Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Transdermal Scopolamine Import and Export Analysis (Top 5 Countries)
-
11.1 Global Transdermal Scopolamine Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Transdermal Scopolamine Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Transdermal Scopolamine Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Transdermal Scopolamine Market Competitive Analysis
-
14.1 Baxter International Inc
-
14.1.1 Baxter International Inc Company Details
-
14.1.2 Baxter International Inc Transdermal Scopolamine Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Baxter International Inc Transdermal Scopolamine Product and Service
-
14.2 Caleb Pharmaceuticals Inc
-
14.2.1 Caleb Pharmaceuticals Inc Company Details
-
14.2.2 Caleb Pharmaceuticals Inc Transdermal Scopolamine Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Caleb Pharmaceuticals Inc Transdermal Scopolamine Product and Service
-
14.3 GlaxoSmithKline plc
-
14.3.1 GlaxoSmithKline plc Company Details
-
14.3.2 GlaxoSmithKline plc Transdermal Scopolamine Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 GlaxoSmithKline plc Transdermal Scopolamine Product and Service
-
14.4 Perrigo Company plc
-
14.4.1 Perrigo Company plc Company Details
-
14.4.2 Perrigo Company plc Transdermal Scopolamine Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Perrigo Company plc Transdermal Scopolamine Product and Service
-
14.5 Novartis AG
-
14.5.1 Novartis AG Company Details
-
14.5.2 Novartis AG Transdermal Scopolamine Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Novartis AG Transdermal Scopolamine Product and Service
-
14.6 Myungmoon Pharma Co LTD
-
14.6.1 Myungmoon Pharma Co LTD Company Details
-
14.6.2 Myungmoon Pharma Co LTD Transdermal Scopolamine Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Myungmoon Pharma Co LTD Transdermal Scopolamine Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Transdermal Scopolamine
-
Figure Transdermal Scopolamine Picture
-
Table Global Transdermal Scopolamine Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Transdermal Scopolamine Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Transdermal Scopolamine Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Transdermal Scopolamine Consumption by Country (2017-2022)
-
Figure United States Transdermal Scopolamine Consumption and Growth Rate (2017-2022)
-
Table Europe Transdermal Scopolamine Consumption and Growth Rate (2017-2022)
-
Figure China Transdermal Scopolamine Consumption and Growth Rate (2017-2022)
-
Figure Japan Transdermal Scopolamine Consumption and Growth Rate (2017-2022)
-
Figure India Transdermal Scopolamine Consumption and Growth Rate (2017-2022)
-
Figure South Korea Transdermal Scopolamine Consumption and Growth Rate (2017-2022)
-
Figure Global Transdermal Scopolamine Consumption Forecast by Country (2022-2028)
-
Figure United States Transdermal Scopolamine Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Transdermal Scopolamine Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Transdermal Scopolamine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Transdermal Scopolamine Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Transdermal Scopolamine Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Transdermal Scopolamine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Tablet Type Consumption and Growth Rate (2017-2022)
-
Figure Global Syrups Type Consumption and Growth Rate (2017-2022)
-
Figure Global Injections Type Consumption and Growth Rate (2017-2022)
-
Figure Global Patch Type Consumption and Growth Rate (2017-2022)
-
Figure Global Gel Type Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Consumption and Growth Rate (2017-2022)
-
Figure Global Clinic Consumption and Growth Rate (2017-2022)
-
Figure Global Ambulance Center Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Tablet Type Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Syrups Type Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Injections Type Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Patch Type Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Gel Type Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Ambulance Center Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Transdermal Scopolamine Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Transdermal Scopolamine Export by Region (Top 5 Countries) (2017-2028)
-
Table Baxter International Inc (Foundation Year, Company Profile and etc.)
-
Table Baxter International Inc Transdermal Scopolamine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Baxter International Inc Transdermal Scopolamine Product and Service
-
Table Caleb Pharmaceuticals Inc (Foundation Year, Company Profile and etc.)
-
Table Caleb Pharmaceuticals Inc Transdermal Scopolamine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Caleb Pharmaceuticals Inc Transdermal Scopolamine Product and Service
-
Table GlaxoSmithKline plc (Foundation Year, Company Profile and etc.)
-
Table GlaxoSmithKline plc Transdermal Scopolamine Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline plc Transdermal Scopolamine Product and Service
-
Table Perrigo Company plc (Foundation Year, Company Profile and etc.)
-
Table Perrigo Company plc Transdermal Scopolamine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Perrigo Company plc Transdermal Scopolamine Product and Service
-
Table Novartis AG (Foundation Year, Company Profile and etc.)
-
Table Novartis AG Transdermal Scopolamine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis AG Transdermal Scopolamine Product and Service
-
Table Myungmoon Pharma Co LTD (Foundation Year, Company Profile and etc.)
-
Table Myungmoon Pharma Co LTD Transdermal Scopolamine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Myungmoon Pharma Co LTD Transdermal Scopolamine Product and Service
-
